Nicole Hijnen

Nicole Hijnen has extensive work experience in various roles and industries. Nicole is currently the President of the Board at Freya Pharma Solutions and a Non-Executive Board Member at SyncVR Medical. Nicole is also an Archangel at Arches Capital and an Active Investor at Fries Innovations B.V. and Newton11 B.V.

Prior to their current roles, Nicole worked at Philips for several years. Nicole held positions such as Business Manager Connected Care, Commercial Director Monitoring & Analytics, Global Proposition & Product Management Lead General Care, Scientist, and Clinical Co-creation Marketing Manager Connected Sensing & Wearables.

Before joining Philips, Nicole was a PhD candidate at Eindhoven University of Technology. Nicole'sresearch focused on the preclinical evaluation of Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) based thermal cancer therapies. Nicole received the Best Biomedical Engineering Doctoral award in 2013 for their work. Nicole also worked as an MSc student at Philips Research.

Nicole Hijnen's education history is as follows:

From 2017 to 2017, they attended Harvard Business School and completed the High Potentials Leadership Program. However, the specific field of study is not provided.

Between 2007 and 2008, Nicole was a graduate student at Caltech, where they pursued a degree in Biomedical Engineering.

From 2002 to 2008, they attended Eindhoven University of Technology. During this period, they completed their Bachelor's degree in Biomedische Technologie and subsequently pursued a Master's degree in Biomedical Engineering with a specialization in Biomecial NMR.